Susquehanna International Group, LLP Certara, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$10.46 - $16.58 $223,844 - $354,811	21,400 New	21,400 $250,000
Q1 2023 May 16, 2023	BUY	$15.9 - $24.72 $748,890 - $1.16 Million	47,100 New	47,100 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$12.84 - $24.13 $223,416 - $419,862	-17,400 Reduced 56.49%	13,400 $178,000
Q2 2022 Aug 15, 2022	BUY	$16.75 - $22.54 $281,400 - $378,672	16,800 Added 120.0%	30,800 $661,000
Q4 2021 Feb 14, 2022	SELL	$26.1 - $45.21 $161,820 - $280,302	-6,200 Reduced 30.69%	14,000 $398,000
Q3 2021 Nov 15, 2021	BUY	$24.46 - $38.41 $494,092 - $775,881	20,200 New	20,200 $669,000
Q2 2021 Aug 11, 2021	SELL	$24.79 - $33.31 $384,245 - $516,305	-15,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.58 - $39.0 $396,490 - $604,500	15,500 New	15,500 $423,000

234

106M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.59B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.